|
1. Foreman JE, Sorg JM, McGinnis KS,
Rigas B, Williams JL, Clapper ML,
Gonzalez FJ,Peters JM.
Regulation of peroxisome proliferator-
activated receptor-beta/delta by
the APC/beta-CANTENIN pathway and
nonsteroidal anti-inflammatory drugs. Mol
carcinog. 2009; in press
2. Zhao W, Mackenzie GG, Murray OT, Zhang
Z. Rigas B. Phosphoaspirin (MDC-43), a
novel benzyl ester of aspirin, inhibits the
growth of human cancer cell lines more
potently than aspirin: A redox-dependent effect. Carcinogenesis 2009; 30:512-9
 To view pdf click here.
3. Sun Y, Chen J, Rigas B. Chemopreventive agents induce oxidative stress in
cancer cells leading to COX-2 overexpression and COX-2-independent cell death.
Carcinogenesis, 2009; 30:93-100
To view pdf click here.
4. Zhou H, Huang L, Sun Y, Rigas B. Nitric oxide-donating aspirin inhibits the
growth of pancreatic cancer cells through redox-dependent signaling.
Cancer Lett, 2009; 273:292-9
To view pdf click here.
5. Sun Y, Rigas B. The thioredoxin system mediates redox-induced cell death in
human colon cancer cells: Implications for the mechanism of action of anticancer
agents. Cancer Res, 2008; 68:8269-77
To view pdf click here.
6. Rigas B, Kozoni V. The novel phenylester anticancer compounds: Study of a
derivative of aspirin (phoshoaspirin). Int J Oncol. 2008; 32:97-100.
Rigas- Kozoni - Int J Oncol.-2008
To view pdf click here.
7. Williams JL, Ji P, Ouyang N, Liu X, Rigas B. NO-donating aspirin inhibits the
activation of NF-kB in human cancer cell lines and Min mice. Carcinogenesis 2008;
29:390-7
To view pdf click here.
8. Wang Y, Zhou Y, Sokolov J, Rigas B, Levon K, Rafailovich M. A
potentiometric protein sensor built with surface molecular imprinting method. Biosens Bioelectron. 24:162-6
To view pdf click here.
9. Rao CV, Joseph S, Gao L, Patlolla J, Choi C-I, Kopelovich L, Steele VE,
Rigas B. Pharmacokinetic and pharmacodynamic study of NO-donating aspirin
in F344 rats. Int J Oncol, 2008; 33:799-805
To view pdf click here.
10. Jiang J, Li C, Lombardi J, Colby RH, Rigas B, Rafailovich MH, Sokolov JC. The
effect of physiologically relevant additives on the rheological properties
of concentrated Pluronic copolymer gels. Polymer, 2008; 49:3561-3567
To view pdf click here.
11. Yang K, Kurihara, N, Fan K, Newmark H, Rigas B, Bancroft L, Corner G,
Livote E, Lesser M, Edelmann W, Velcich A, Lipkin M, Augenlicht L. Dietary
inductionof colonic tumors in a mouse model of sporadic colon cancer. Cancer
Res, 2008;68:7803-10
12. Rigas B. Williams JL NO-donating NSAIDs and cancer: An overview with a
note on whether NO is required for their action. Nitric Oxide. 2008; 19:199-204.
To view pdf click here.
13. Rasheed S, Rigas B. Screening for colorectal cancer: Does it all start with
aberrant crypt foci? Gastrointestinal Endoscopy, 2008; 67:1103-5.
To view pdf click here.
14. Rigas B, Rao CV, Cooney R, Singh S. Food components, alternative medicine
and cancer: Progress and promise, Nutr Cancer, 2008; 60(S):1-1
15. Rigas B, Sun Y. Induction of oxidative stress as a mechanism of action of
chemopreventive agents against cancer. Br J Cancer, 2008; 98:1157-60.
To view pdf click here.
16.. Mackenzie GG, Rasheed S, Wertheim W, Rigas B. NO-donating NSAIDs,
PPARδ and cancer: Does PPARδ contribute to colon carcinogenesis? PPAR Res,
2008; 2008:919572.
To view pdf click here.
1. Rigas B. The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs
in the chemoprevention of colorectal neoplasia. Curr Opin Gastroenterol.
2007;23:55-9
To view pdf click here.
2. Kashi K, Rigas B. The mechanism of action of nitric oxide-donating aspirin.
Biochem Biophys Res Commun. 2007;358:1096-101
To view pdf click here.
3. McIlhatton MA, Tyler J, Burkholder S, Ruschoff J, Rigas B, Kopelovich L,
Fishel R. Nitric oxide-donating aspirin derivatives suppress microsatellite
instability in mismatch repair-deficient and hereditary nonpolyposis colorectal
cancer cells. Cancer Res 2007;67:10966-75
To view pdf click here.
|
Recent papers